title: Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant).
abstract: A certain relationship was observed between the gastrointestinal system, arthritis and immune system. Patients with rheumatoid arthritis have an altered microflora composition and disturbed intestinal defensive barrier. Effect of probiotic bacteria (Colinfant; COL) with known favorable effect on intestinal microflora was determined on the methotrexate (MTX) treatment of adjuvant arthritis. Rats with adjuvant arthritis were administered methotrexate 0.5 mg/kg body mass 2-times weekly per os, COL 1 mL/kg body mass every second day per os, and a combination of MTX+COL for a period of 28 d from the immunization. Levels of serum albumin, body mass, changes in hind paw swelling, and arthrogram score were estimated in rats as variables of inflammation and destructive arthritis-associated changes. Treatment with MTX, as well as with the combination treatment with MTX+COL significantly inhibited both inflammation and destructive arthritis-associated changes. The combination treatment inhibited both the hind paw swelling and arthrogram score more remarkably than MTX alone; on the other hand, the difference between combination treatment and MTX alone was not significant. Treatment with COL alone had no effect on adjuvant arthritis in rats. Colinfant can increase the preventive effect of MTX treatment in rat adjuvant arthritis by improving its antiarthritic effects.
authors.affiliation: National Institute of Rheumatic Diseases, 921 01 Piestany, Slovakia. rovensky.jozef@nurch.sk
authors.forename: J
authors.initials: J
authors.lastname: Rovenský
authors.forename: M
authors.initials: M
authors.lastname: Stancíková
authors.forename: K
authors.initials: K
authors.lastname: Svík
authors.forename: J
authors.initials: J
authors.lastname: Utesený
authors.forename: K
authors.initials: K
authors.lastname: Bauerová
authors.forename: J
authors.initials: J
authors.lastname: Jurcovicová
mesh_terms: D000818:Animals; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001169:Arthritis, Experimental / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000502:physiology; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D019936:Probiotics / Q000008:administration & dosage*; D051381:Rats; D011917:Rats, Inbred Lew
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate